ODDB.org: Open Drug Database

UCB-Pharma SA - Vimpat 150 mg, comprimés pelliculés

Swissmedic Registration	59002	Sequence	03
Product name	Vimpat 150 mg	Description	comprimés pelliculés
ATC-Classification	N03AX18	ATC-Description	Lacosamide
Introduction of Sequence	28.08.2009

Composition

lacosamidum 150 mg, cellulosum microcristallinum, hydroxypropylcellulosum substitutum humile, cellulosum microcristallinum silicificatum, crospovidonum, magnesii stearas, hydroxypropylcellulosum, pellicule: poly(alcohol vinylicus), talcum, macrogolum 3350, E 171, E 172 (flavum), E 172 (rubrum), E 172 (nigrum) pro compresso obducto.

Packungsbestandteile

Galenic Form

Coated tablets

Active Agent	Dose
Lacosamidum	150 mg

BAG: Active Agent	Dose
Lacosamidum	150 mg

Inactive agents	Dose	additional_information
(Flavum)
(Nigrum) pro Compresso Obducto
(Rubrum)
Cellulosum Microcristallinum
Cellulosum Microcristallinum Silicificatum
Crospovidonum
E 171		color.
E 172		color.
Hydroxypropylcellulosum
Hydroxypropylcellulosum Substitutum Humile
Macrogol	3350
Magnesii Stearas
Poly(Alcohol Vinylicus)		pellicule
Talcum

Package number	Package Size	EFP	CP	Category	SL	Out of trade (MedRef)
005	14 Tablet(s)	15.79	33.35	B	SL	No
006	168 Tablet(s)	175.39	204.45	B	SL	No
014	56 Tablet(s)	59.98	80.75	B	SL	No

2025	©ywesee GmbH